Identification and Distribution of Fibrinogen, Fibrin, and Fibrin(ogen) Degradation Products in Atherosclerosis. Use of Monoclonal Antibodies

Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
doi 10.1161/01.atv.9.1.109
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Urinary and Serum Fibrin/Fibrinogen Degradation Products in Renal Transplant Rejection

Japanese Journal of Urology
Urology
1977English

Fibrin Degradation Products.

BMJ
1970English

Serial Estimation of Urinary Fibrin/Fibrinogen Degradation Products in Kidney Transplantation

BMJ
1973English

Modification by Drugs of Urinary Fibrin Fibrinogen Degradation Products in Glomerulonephritis

BMJ
1972English

Fibrin Degradation Products.

BMJ
1969English

Effect of Fibrin and Fibrinogen Proteolysis Products on Clot Physical Properties

American Journal of Physiology-Legacy Content
1965English

Serum Amyloid a Binds to Fibrin(ogen), Promoting Fibrin Amyloid Formation

Scientific Reports
Multidisciplinary
2019English

Fibrin(ogen) and Diabetes Mellitus: Don't Forget Fibrinolysis

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1997English

Fibrinogen and Fibrin: An Illustrated Review

Research and Practice in Thrombosis and Haemostasis
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy